Companies: 10,795·Total market cap: $144.5T
Ping An Biomedical Co., Ltd.

Ping An Biomedical Co., Ltd.

PASWNASDAQIndustrials● Active
$0.17
+$0.01(+7.76%)
Market Cap$3205989
P/E Ratio
52W High$5.4
52W Low$0.121
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Ping An Biomedical Co., Ltd. (PASW) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001897532 · PASW · NASDAQ · as of Jun 8, 2026

Filing snapshot

99
Total Filings
6-K
Latest Form
2026-05-27
Most Recent
2025
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001897532 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-01-30
Fiscal Year End
Jan 30, 2026
Accession No.
0001213900-26-010078
Primary Document
ea0273868-20f_pingan.htm
Source: data.sec.gov · CIK 0001897532 · Accession 0001213900-26-010078

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-27
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-27
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-08
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-01
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-01
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-19
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-09
View
EFFECTEFFECT
EFFECT
2026-02-26
View
CORRESPCORRESP
CORRESP
2026-02-24
View
UPLOADUPLOAD
UPLOAD
2026-02-20
View
F-1F-1
REGISTRATION STATEMENT
2026-02-13
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-02-12
View
20-FAnnual Report (Foreign Issuer)
ANNUAL REPORT
2026-01-30
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-01-12
View
Showing 1–15 of 99 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001897532  |  Exchange: NASDAQ · Industrials

Ping An Biomedical Co., Ltd. (NASDAQ: PASW) has submitted 99 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2025. As a Industrials sector company with CIK 0001897532, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Ping An Biomedical Co., Ltd.'s most comprehensive regulatory disclosure. The most recent Ping An Biomedical Co., Ltd. 10-K was filed on 2026-01-30 for fiscal year ending 2026. Historical PASW 10-K annual reports are available from 2021 through 2026.

Investors researching Ping An Biomedical Co., Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

PASW SEC Filings · 8 questions

Ping An Biomedical Co., Ltd. (PASW) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 99 filings and access original documents at no cost. Ping An Biomedical Co., Ltd.'s CIK is 0001897532.

PASW SEC filingsPing An Biomedical Co., Ltd. SEC documentsfind PASW 10-K